Vitiligo in the affected breast during neo-adjuvant chemotherapy for breast cancer

Breast Cancer Res Treat. 2009 Sep;117(1):197-8. doi: 10.1007/s10549-008-0074-6. Epub 2008 Jul 1.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Carcinoma, Ductal, Breast / drug therapy*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Neoadjuvant Therapy
  • Vitiligo / chemically induced*

Substances

  • Doxorubicin
  • Cyclophosphamide